| 價(jià)格 | ¥108 | ¥213 | ¥328 |
| 包裝 | 1mg | 5mg | 10mg |
| 最小起訂量 | 1mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-05-08 |
| 中文名稱:姜酮酚 | 英文名稱:Paradol |
| CAS:27113-22-0 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 純度規(guī)格: 98.65% | 產(chǎn)品類別: 抑制劑 |
| 貨號(hào): T006|T7113 |
| 名稱 | Paradol |
| 描述 | Paradol ([6]-Gingerone) is a pungent phenolic substance found in ginger and other Zingiberaceae plants, and exhibits a variety of biological activities including anti-cancer, anti-inflammatory, and anti-oxidative activities,neuroprotective Effects. |
| 動(dòng)物實(shí)驗(yàn) | MOG35-55 was emulsified in an equal amount of CFA.?Mice were anesthetized with isoflurane and 200 μg of emulsion MOG35-55 in CFA was injected subcutaneously at the start day of immunization (day 1). In addition, 400 ng of Bordetella pertussis toxin (PTX) per mouse was injected intraperitoneally on the start day of MOG immunization and 2 days later.?Mice were weighed and monitored daily for clinical symptoms of EAE as follows: 0, no clinical signs of EAE;?0.5, some lack of tone, however, some strength at the base of tail;?1.0, total loss of tail tonicity and flaccid tail;?2.0, hind limb weakness;?2.5, incomplete paralysis of one or both hind limbs;?3.0, total paralysis of one or both hind limbs;?4.0, hind and fore limbs paralysis;?5.0, death from disease.?For drug administration, symptomatic EAE mice were divided into three groups;?(1) the vehicle-treated EAE group, (2) the 6-shogaol-treated EAE group, and (3) the 6-paradol-treated EAE group.?Vehicle (10% Tween 80), 6-shogaol (5 mg/kg), or 6-paradol (5 mg/kg) was orally administered daily into symptomatic EAE mice from day 29 to day 42 (for 13 days) post immunization[1]. |
| 體內(nèi)活性 | EAE癥狀型小鼠自免疫后第29天起,每日一次口服Paradol或6-帕拉多(5 mg/kg),持續(xù)14天(至第42天)。自給藥第四天起(第32至42天),除了6-帕拉多處理組的EAE小鼠在第36和37天外,Paradol和6-帕拉多顯著改善了EAE相關(guān)癥狀,與對(duì)照組(車用處理組)相比(圖1A,補(bǔ)充表1)。從第30天到第43天的累積臨床評(píng)分也清楚地顯示了Paradol和6-帕拉多的有效性。6-帕拉多或Paradol的給藥顯著降低了累積臨床評(píng)分(Paradol,25.25%;6-帕拉多,25.75%),與對(duì)照組相比。Paradol及其代謝物6-帕拉多,對(duì)EAE具有神經(jīng)保護(hù)作用。此外,這些分子對(duì)EAE具有治療效果[1]。 |
| 存儲(chǔ)條件 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+90% Saline : < 10 mg/mL (35.92 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 250 mg/mL (898.02 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (35.92 mM), Solution. |
| 關(guān)鍵字 | Paradol | Inhibitor | inhibit | Cyclooxygenase | COX-2 | COX | [6]-Paradol |
| 相關(guān)產(chǎn)品 | Trometamol | Gallic Acid Monohydrate | Naproxen sodium | Guaiacol | 5-Methylfurfural | Phenylbutazone | 5-Aminosalicylic Acid | Revaprazan hydrochloride | Rebamipide | Acetaminophen | Diclofenac Potassium | Magnesium sulfate |
| 相關(guān)庫(kù) | 神經(jīng)保護(hù)化合物庫(kù) | 抗癌活性化合物庫(kù) | 已知活性化合物庫(kù) | 植物來(lái)源化合物庫(kù) | 古代經(jīng)典名方目錄分子庫(kù) | 苗藥化合物庫(kù) | 抗衰老化合物庫(kù) | 中藥單體化合物庫(kù) | 免疫/炎癥分子化合物庫(kù) | 中藥抗炎分子庫(kù) | 疼痛相關(guān)化合物庫(kù) | 高通量篩選天然產(chǎn)物庫(kù) |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP7年
|
南京擇優(yōu)新材料科技有限公司
|
2026-07-27 | |
| 詢價(jià) |
VIP3年
|
湖北萃園生物科技有限公司
|
2026-07-27 | |
| 詢價(jià) |
VIP6年
|
武漢華玖醫(yī)藥科技有限公司
|
2026-07-27 | |
| ¥5000 |
VIP9年
|
山東豐泰生物科技有限公司
|
2026-07-27 | |
| ¥3800 |
VIP3年
|
金華市佰康生物工程有限公司
|
2026-07-27 | |
| 詢價(jià) |
VIP7年
|
山西玉寧生物科技有限公司
|
2026-07-27 | |
| 詢價(jià) |
VIP14年
|
蘇州麥輪生物科技有限公司
|
2026-07-17 | |
| ¥600 |
VIP1年
|
江蘇創(chuàng)升生物工程有限公司
|
2026-07-06 | |
| 詢價(jià) |
VIP1年
|
湖北省漢卿生物醫(yī)藥科技有限公司
|
2026-07-01 | |
| ¥125.90 |
VIP14年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-23 |